1. Sun, Nannan, Shen, Chuangpeng, Zhang, Lei, Chang, Yongsheng, Gao, Yong. 2020. Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance. In Gut, 70, 2183-2195. doi:10.1136/gutjnl-2020-321774. https://pubmed.ncbi.nlm.nih.gov/33257471/
2. Chen, Xiaosong, Wang, Ping, Ou, Tongwen, Li, Jin. 2022. KLF16 Downregulates the Expression of Tumor Suppressor Gene TGFBR3 to Promote Bladder Cancer Proliferation and Migration. In Cancer management and research, 14, 465-477. doi:10.2147/CMAR.S334521. https://pubmed.ncbi.nlm.nih.gov/35173481/
3. Yuce, Kemal, Ozkan, Ahmet Ismail. 2023. The kruppel-like factor (KLF) family, diseases, and physiological events. In Gene, 895, 148027. doi:10.1016/j.gene.2023.148027. https://pubmed.ncbi.nlm.nih.gov/38000704/
4. Lim, Elaine T, Uddin, Mohammed, De Rubeis, Silvia, Buxbaum, Joseph D, Walsh, Christopher A. 2017. Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder. In Nature neuroscience, 20, 1217-1224. doi:10.1038/nn.4598. https://pubmed.ncbi.nlm.nih.gov/28714951/